Inhibition of breast cancer progression by an antibody to a thrombospondin-1 receptor
Authors:
- Xiao-Hua QianXQXiao-Hua Qian
- Mark S. GranickMGMark S. Granick
- Mark P. SolomonMSMark P. Solomon
- Vicki L. RothmanVRVicki L. Rothman
- David H. BergerDBDavid H. Berger
- George P. TuszynskiGTGeorge P. Tuszynski
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Thrombospondin (TSP) and Transforming Growth Factor β 1 (TGF-β) Promote Human A549 Lung Carcinoma Cell Plasminogen Activator Inhibitor Type 1 (Pal-1) Production and Stimulate Tumor Cell Attachment in VitroBiochemical and Biophysical Research Communications, 1994
- Matrix-bound thrombospondin promotes angiogenesis in vitroJournal of Cell Biology, 1994
- Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.Journal of Clinical Investigation, 1993
- The thrombospondin familyCurrent Biology, 1993
- Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor.Journal of Cell Biology, 1990
- Characterization of thrombospondin synthesis, secretion and cell surface expression by human tumor cellsClinical & Experimental Metastasis, 1989
- Thrombospondin in malignant and non-malignant breast tissueEuropean Journal of Cancer and Clinical Oncology, 1989
- Thrombospondin-induced adhesion of human keratinocytes.Journal of Clinical Investigation, 1988
- Thrombospondin Promotes Cell-Substratum AdhesionScience, 1987
- Synthesis and secretion of thrombospondin by cultured human endothelial cells.Journal of Cell Biology, 1982